Medivir Presents at the Rodman & Renshaw Conference

Medivir has participated in, and was today presented before, the Acumen BioFin Rodman & Renshaw 5th Annual Healthcare Conference in Monaco. The presentation provides an update on Medivir's projects, including the newly signed deal with Tibotec on HCV polymerase inhibitors.

The presentation is now available on Medivir's website under the Investor&Media/Latest events tab.


For additional information, please contact
Rein Piir, CFO & VP Investor Relations, Medivir +46 708 537 292.


For more on Medivir, please see the company website: www.medivir.se